Bioequivalence and Bioavailability Forum • EMA MR: long half life → MD

EMA MR: long half life → MD [Design Issues]

posted by Loky do – Egypt, 2020-08-09 21:06 (911 d 09:42 ago) – Posting: # 21845
Views: 1,777

Thanks, Helmut your response always very helpful for us ;-)

Complete thread:

multiple dose bioequivalence study Loky do 2020-08-09 11:50 [Design Issues]
- EMA MR: long half life → MD Helmut 2020-08-09 12:08
  - EMA MR: long half life → MDLoky do 2020-08-09 19:06
- multiple dose bioequivalence study wienui 2020-08-10 08:00

Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
38 visitors (0 registered, 38 guests [including 16 identified bots]).
Forum time: 05:48 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce. Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz